Tech Watches You for Digital Symptoms of Brain Disorders (IEEE Spectrum):
The medical professionals tasked with caring for our minds don’t have an easy job. To diagnose people with neuropsychiatric diseases, doctors can perform brain scans, but such scans are expensive and the results are sometimes inscrutable. The other options include conducting time-consuming cognitive tests, or relying on doctors’ own subjective analyses.
Seeing an opportunity, a number of startups have devised quantitative methods to diagnose diseases or assess mental health while patients complete routine activities, like talking on a smartphone, typing on a keyboard, or scrolling through a website. Here are three companies that say they can lift the “fingerprints” of mental disorders from people’s mundane behaviors.
Continue reading article to get a good update on Mindstrong Health, NeuraMetrix and WinterLight Labs.
News in Context:
- Mindstrong Health identifies digital biomarkers of cognitive function using smartphone data
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
- Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health
- Mindstrong Health raises $14 million to modernize the diagnosis and treatment of neuropsychiatric disorders
- Pending FDA review and approval, research findings pave way for Akili’s EVO to become first brain training platform prescribed for ADHD
- Neurotechnology can improve our lives…if we first address these Privacy and Informed Consent issues
Overview of the brain & mental health innovation landscape:
- Upcoming event: 2018 SharpBrains Virtual Summit (December 4–6th, 2018)
- Presentations by Mindstrong Health, Savonix, HealthTech Connex and NeuraMetrix at the 2017 SharpBrains Virtual Summit: Brain Health & Enhancement in the Digital Age (December 5–7th, 2017):